{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:20:33Z","timestamp":1794986433410,"version":"4.9.1"},"reference-count":204,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CD4+ T helper (Th) cells exist in a variety of epigenetic states that determine their function, phenotype, and capacity for persistence. These polarization states include Th1, Th2, Th17, and Foxp3+ T regulatory cells, as well as the more recently described T follicular helper, Th9, and Th22 cells. Th17 cells express the master transcriptional regulator retinoic acid\u2013related orphan receptor \u03b3 thymus and produce canonical interleukin (IL)-17A and IL-17F cytokines. Th17 cells display a great degree of context-dependent plasticity, as they are capable of acquiring functional characteristics of Th1 cells. This late plasticity may contribute to the protection against microbes, plays a role in the development of autoimmunity, and is necessary for antitumor activity of Th17 cells in adoptive cell transfer therapy models. Moreover, plasticity of this subset is associated with higher in vivo survival and self-renewal capacity and less senescence than Th1 polarized cells, which have less plasticity and more phenotypic stability. New findings indicate that subset polarization of CD4+ T cells not only induces characteristic patterns of surface markers and cytokine production but also has a maturational aspect that affects a cell\u2019s ability to survive, respond to secondary stimulation, and form long-term immune memory.<\/jats:p>","DOI":"10.1182\/blood-2012-09-378653","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:22:12Z","timestamp":1358382132000},"page":"2402-2414","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":355,"title":["Essentials of Th17 cell commitment and plasticity"],"prefix":"10.1182","volume":"121","author":[{"given":"Pawel","family":"Muranski","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Restifo","sequence":"additional","affiliation":[{"name":"Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111809442762300_B1","author":"Zhu"},{"key":"2019111809442762300_B2","author":"Sun"},{"issue":"8","key":"2019111809442762300_B3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1413","article-title":"Helping the CD8(+) T-cell response.","volume":"4","author":"Bevan","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111809442762300_B4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4\u207a T cells in immunity to viruses.","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111809442762300_B5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.coi.2009.02.004","article-title":"Adoptive immunotherapy of cancer using CD4(+) T cells.","volume":"21","author":"Muranski","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"2019111809442762300_B6","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"2019111809442762300_B7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2019111809442762300_B8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.","volume":"169","author":"Heinzel","year":"1989","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809442762300_B9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm.","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol Today"},{"issue":"3","key":"2019111809442762300_B10","first-page":"823","article-title":"Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn\u2019s disease.","volume":"150","author":"Parronchi","year":"1997","journal-title":"Am J Pathol"},{"issue":"1","key":"2019111809442762300_B11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.181.1.381","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.","volume":"181","author":"Leonard","year":"1995","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809442762300_B12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ni794","article-title":"T-bet is a STAT1-induced regulator of IL-12R expression in na\u00efve CD4+ T cells.","volume":"3","author":"Afkarian","year":"2002","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111809442762300_B13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment.","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"issue":"2","key":"2019111809442762300_B14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.coi.2011.12.004","article-title":"Transcriptional mechanisms that regulate T helper 1 cell differentiation.","volume":"24","author":"Oestreich","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2019111809442762300_B15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","article-title":"Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.","volume":"4","author":"Kaplan","year":"1996","journal-title":"Immunity"},{"issue":"4","key":"2019111809442762300_B16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"issue":"6575","key":"2019111809442762300_B17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/380630a0","article-title":"Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.","volume":"380","author":"Shimoda","year":"1996","journal-title":"Nature"},{"issue":"5","key":"2019111809442762300_B18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.","volume":"326","author":"Robinson","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111809442762300_B19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI8107","article-title":"Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation.","volume":"106","author":"Lambrecht","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111809442762300_B20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.173.1.159","article-title":"Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni.","volume":"173","author":"Pearce","year":"1991","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809442762300_B21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1074-7613(95)90011-X","article-title":"Developmental commitment to the Th2 lineage by extinction of IL-12 signaling.","volume":"2","author":"Szabo","year":"1995","journal-title":"Immunity"},{"issue":"5","key":"2019111809442762300_B22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1074-7613(00)80671-8","article-title":"Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism.","volume":"9","author":"Ouyang","year":"1998","journal-title":"Immunity"},{"issue":"3","key":"2019111809442762300_B23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20052165","article-title":"T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.","volume":"203","author":"Usui","year":"2006","journal-title":"J Exp Med"},{"key":"2019111809442762300_B24","author":"Hwang"},{"issue":"2","key":"2019111809442762300_B25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.it.2011.10.005","article-title":"T-bet employs diverse regulatory mechanisms to repress transcription.","volume":"33","author":"Oestreich","year":"2012","journal-title":"Trends Immunol"},{"key":"2019111809442762300_B26","author":"Hori"},{"issue":"6924","key":"2019111809442762300_B27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"issue":"12","key":"2019111809442762300_B28","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"2019111809442762300_B29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111809442762300_B30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111809442762300_B31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"2","key":"2019111809442762300_B32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809442762300_B33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"2019111809442762300_B34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"1","key":"2019111809442762300_B35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"2019111809442762300_B36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"issue":"7253","key":"2019111809442762300_B37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08114","article-title":"The AP-1 transcription factor Batf controls T(H)17 differentiation.","volume":"460","author":"Schraml","year":"2009","journal-title":"Nature"},{"key":"2019111809442762300_B38","author":"Shi"},{"issue":"9","key":"2019111809442762300_B39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni1500","article-title":"The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.","volume":"8","author":"Br\u00fcstle","year":"2007","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111809442762300_B40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells.","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"2019111809442762300_B41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification.","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"issue":"3","key":"2019111809442762300_B42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"issue":"3","key":"2019111809442762300_B43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ni.1969","article-title":"T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding ROR\u03b3t.","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat Immunol"},{"key":"2019111809442762300_B45","author":"Diveu"},{"issue":"8","key":"2019111809442762300_B46","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells.","volume":"178","author":"Mathur","year":"2007","journal-title":"J Immunol"},{"issue":"13","key":"2019111809442762300_B47","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111809442762300_B48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"issue":"3","key":"2019111809442762300_B49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo.","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111809442762300_B50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.smim.2007.10.015","article-title":"Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.","volume":"19","author":"Chen","year":"2007","journal-title":"Semin Immunol"},{"issue":"9","key":"2019111809442762300_B51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"issue":"7152","key":"2019111809442762300_B52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"issue":"7318","key":"2019111809442762300_B53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling.","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"2019111809442762300_B54","author":"Dinarello"},{"issue":"5","key":"2019111809442762300_B55","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.immuni.2012.08.019","article-title":"Inactivation of the enzyme GSK3\u03b1 by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance.","volume":"37","author":"Gulen","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.immuni.2009.12.003","article-title":"The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.","volume":"32","author":"Gulen","year":"2010","journal-title":"Immunity"},{"issue":"4","key":"2019111809442762300_B57","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"2019111809442762300_B58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2008.10.011","article-title":"IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor.","volume":"29","author":"Chen","year":"2008","journal-title":"Immunity"},{"issue":"1-2","key":"2019111809442762300_B59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jim.2010.09.008","article-title":"Depletion of TGF-\u03b2 from fetal bovine serum.","volume":"362","author":"Oida","year":"2010","journal-title":"J Immunol Methods"},{"issue":"3","key":"2019111809442762300_B60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.immuni.2011.03.005","article-title":"Autocrine transforming growth factor-\u03b21 promotes in vivo Th17 cell differentiation.","volume":"34","author":"Gutcher","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.0801986","article-title":"TGF-beta promotes Th17 cell development through inhibition of SOCS3.","volume":"183","author":"Qin","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"2019111809442762300_B62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"7192","key":"2019111809442762300_B63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"issue":"45","key":"2019111809442762300_B64","doi-asserted-by":"crossref","first-page":"19402","DOI":"10.1073\/pnas.1008247107","article-title":"Human ROR\u03b3t+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors.","volume":"107","author":"Valmori","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111809442762300_B65","author":"Mucida"},{"issue":"6","key":"2019111809442762300_B66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ni.2286","article-title":"TGF-\u03b2 and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells.","volume":"13","author":"Takahashi","year":"2012","journal-title":"Nat Immunol"},{"issue":"3","key":"2019111809442762300_B67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.immuni.2011.03.003","article-title":"Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha.","volume":"34","author":"Hall","year":"2011","journal-title":"Immunity"},{"issue":"7191","key":"2019111809442762300_B68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"issue":"2","key":"2019111809442762300_B69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.smim.2011.01.008","article-title":"External influences on the immune system via activation of the aryl hydrocarbon receptor.","volume":"23","author":"Stockinger","year":"2011","journal-title":"Semin Immunol"},{"issue":"6","key":"2019111809442762300_B70","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells.","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"issue":"3","key":"2019111809442762300_B71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria.","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"2019111809442762300_B72","author":"Kriegel"},{"issue":"6","key":"2019111809442762300_B73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2011.10.018","article-title":"Th17 cells mediate clade-specific, serotype-independent mucosal immunity.","volume":"35","author":"Chen","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni.1826","article-title":"Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells.","volume":"11","author":"Pepper","year":"2010","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111809442762300_B75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation.","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"2019111809442762300_B76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2019111809442762300_B77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells.","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2019111809442762300_B78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family.","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2019111809442762300_B79","author":"Fossiez"},{"issue":"10","key":"2019111809442762300_B80","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.176.10.6186","article-title":"IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation.","volume":"176","author":"Tan","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"2019111809442762300_B81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0016-5085(00)70351-9","article-title":"Claudins regulate the intestinal barrier in response to immune mediators.","volume":"118","author":"Kinugasa","year":"2000","journal-title":"Gastroenterology"},{"issue":"7","key":"2019111809442762300_B82","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni.2053","article-title":"The development of inducible bronchus-associated lymphoid tissue depends on IL-17.","volume":"12","author":"Rangel-Moreno","year":"2011","journal-title":"Nat Immunol"},{"issue":"7090","key":"2019111809442762300_B83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage.","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"4","key":"2019111809442762300_B84","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111809442762300_B85","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"2019111809442762300_B86","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ni1460","article-title":"Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.","volume":"8","author":"LeibundGut-Landmann","year":"2007","journal-title":"Nat Immunol"},{"key":"2019111809442762300_B87","first-page":"115","article-title":"Adaptive immunity to fungi.","volume-title":"Annual Review of Immunology","author":"Wuthrich"},{"key":"2019111809442762300_B88","author":"Liang"},{"issue":"3","key":"2019111809442762300_B89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia.","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"2019111809442762300_B90","author":"Spolski"},{"issue":"7188","key":"2019111809442762300_B91","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"issue":"2","key":"2019111809442762300_B92","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/COH.0b013e328335ed3e","article-title":"Th17 cells, Job\u2019s syndrome and HIV: opportunities for bacterial and fungal infections.","volume":"5","author":"Milner","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"2019111809442762300_B93","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"2019111809442762300_B94","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2008-05-159301","article-title":"Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.","volume":"112","author":"Brenchley","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111809442762300_B95","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI0215751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.","volume":"110","author":"Becher","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111809442762300_B96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2019111809442762300_B97","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00277-008-0666-6","article-title":"Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia.","volume":"88","author":"Takaku","year":"2009","journal-title":"Ann Hematol"},{"key":"2019111809442762300_B98","author":"Zwiers"},{"issue":"4","key":"2019111809442762300_B99","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.4049\/jimmunol.1100767","article-title":"IL-21 promotes the pathologic immune response to pneumovirus infection.","volume":"188","author":"Spolski","year":"2012","journal-title":"J Immunol"},{"issue":"4","key":"2019111809442762300_B100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption.","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J"},{"issue":"6","key":"2019111809442762300_B101","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"issue":"8","key":"2019111809442762300_B102","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20090246","article-title":"IL-9 as a mediator of Th17-driven inflammatory disease.","volume":"206","author":"Nowak","year":"2009","journal-title":"J Exp Med"},{"issue":"6","key":"2019111809442762300_B103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111809442762300_B104","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111809442762300_B105","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.","volume":"205","author":"Luger","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"2019111809442762300_B106","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"2019111809442762300_B107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ni.1802","article-title":"Autoimmunity: increasing suspects in the CD4+ T cell lineup.","volume":"11","author":"Palmer","year":"2010","journal-title":"Nat Immunol"},{"issue":"7","key":"2019111809442762300_B108","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.20082584","article-title":"T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.","volume":"206","author":"Yang","year":"2009","journal-title":"J Exp Med"},{"issue":"10","key":"2019111809442762300_B109","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells.","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"issue":"9","key":"2019111809442762300_B110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(08)70173-X","article-title":"Repeated subcutaneous injections of IL12\/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.","volume":"7","author":"Segal","year":"2008","journal-title":"Lancet Neurol"},{"issue":"5","key":"2019111809442762300_B111","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"2019111809442762300_B112","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis.","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2019111809442762300_B113","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.","volume":"118","author":"Ma","year":"2008","journal-title":"J Clin Invest"},{"issue":"9625","key":"2019111809442762300_B114","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"issue":"7","key":"2019111809442762300_B115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nbt.1903","article-title":"Therapeutic targeting of the IL-12\/23 pathways: generation and characterization of ustekinumab.","volume":"29","author":"Benson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"13","key":"2019111809442762300_B116","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111809442762300_B117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","article-title":"Interleukin-23 drives intestinal inflammation through direct activity on T cells.","volume":"33","author":"Ahern","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"2019111809442762300_B118","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156652412800620066","article-title":"Th17-related cytokines in inflammatory bowel diseases: friends or foes?","volume":"12","author":"Monteleone","year":"2012","journal-title":"Curr Mol Med"},{"issue":"6","key":"2019111809442762300_B119","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.1736","article-title":"A protective function for interleukin 17A in T cell-mediated intestinal inflammation.","volume":"10","author":"O\u2019Connor","year":"2009","journal-title":"Nat Immunol"},{"issue":"2","key":"2019111809442762300_B120","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111809442762300_B121","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"issue":"11","key":"2019111809442762300_B122","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","article-title":"IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.","volume":"37","author":"Fantini","year":"2007","journal-title":"Eur J Immunol"},{"issue":"2","key":"2019111809442762300_B123","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes.","volume":"178","author":"Peluso","year":"2007","journal-title":"J Immunol"},{"key":"2019111809442762300_B124","author":"Annunziato"},{"issue":"8","key":"2019111809442762300_B125","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.","volume":"205","author":"Cosmi","year":"2008","journal-title":"J Exp Med"},{"issue":"12","key":"2019111809442762300_B126","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial.","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"issue":"4","key":"2019111809442762300_B127","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn\u2019s disease.","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"issue":"7293","key":"2019111809442762300_B128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"2019111809442762300_B129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease.","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol Rev"},{"issue":"12","key":"2019111809442762300_B130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.it.2011.08.003","article-title":"Deciphering the role of Th17 cells in human disease.","volume":"32","author":"Wilke","year":"2011","journal-title":"Trends Immunol"},{"issue":"7344","key":"2019111809442762300_B131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"issue":"7344","key":"2019111809442762300_B132","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing ROR\u03b3t activity.","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"issue":"6","key":"2019111809442762300_B133","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy.","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"1 Suppl","key":"2019111809442762300_B134","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.bbmt.2011.10.001","article-title":"The IL-17 differentiation pathway and its role in transplant outcome.","volume":"18","author":"Serody","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2019111809442762300_B135","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/bmt.2010.28","article-title":"Prognostic significance of genetic variants in the IL-23\/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation.","volume":"45","author":"Carvalho","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"2019111809442762300_B136","author":"Carlson"},{"issue":"4","key":"2019111809442762300_B137","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2008-08-172155","article-title":"IL-17 contributes to CD4-mediated graft-versus-host disease.","volume":"113","author":"Kappel","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111809442762300_B138","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbmt.2009.09.023","article-title":"T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.","volume":"16","author":"Iclozan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111809442762300_B139","author":"Yu"},{"issue":"2","key":"2019111809442762300_B140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2012.05.027","article-title":"STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.","volume":"37","author":"Laurence","year":"2012","journal-title":"Immunity"},{"key":"2019111809442762300_B141","author":"Fulton"},{"issue":"26","key":"2019111809442762300_B142","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation.","volume":"114","author":"Bucher","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111809442762300_B143","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"issue":"25","key":"2019111809442762300_B144","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1182\/blood-2009-11-255422","article-title":"Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.","volume":"115","author":"Das","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111809442762300_B145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2011-01-332478","article-title":"Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.","volume":"119","author":"Nishimori","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111809442762300_B146","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"4","key":"2019111809442762300_B147","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccr.2011.03.018","article-title":"The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.","volume":"19","author":"Li","year":"2011","journal-title":"Cancer Cell"},{"issue":"10","key":"2019111809442762300_B148","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.","volume":"118","author":"Kujawski","year":"2008","journal-title":"J Clin Invest"},{"issue":"12","key":"2019111809442762300_B149","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"2019111809442762300_B150","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","article-title":"Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.","volume":"178","author":"Kryczek","year":"2007","journal-title":"J Immunol"},{"key":"2019111809442762300_B151","author":"Kryczek"},{"issue":"2","key":"2019111809442762300_B152","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood-2009-04-215541","article-title":"Does IL-17 promote tumor growth?","volume":"114","author":"Muranski","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111809442762300_B153","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumour immunity and immunotherapy.","volume":"10","author":"Zou","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"15","key":"2019111809442762300_B154","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res"},{"issue":"7","key":"2019111809442762300_B155","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.","volume":"206","author":"Wang","year":"2009","journal-title":"J Exp Med"},{"issue":"5","key":"2019111809442762300_B156","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells.","volume":"184","author":"He","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"2019111809442762300_B157","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood.V99.6.2114","article-title":"Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism.","volume":"99","author":"Benchetrit","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111809442762300_B158","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/blood-2008-09-177360","article-title":"Endogenous IL-17 contributes to reduced tumor growth and metastasis.","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111809442762300_B159","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","article-title":"Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.","volume":"36","author":"Chalmin","year":"2012","journal-title":"Immunity"},{"issue":"7101","key":"2019111809442762300_B160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","article-title":"IL-23 promotes tumour incidence and growth.","volume":"442","author":"Langowski","year":"2006","journal-title":"Nature"},{"issue":"11","key":"2019111809442762300_B161","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1084\/jem.20111106","article-title":"Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.","volume":"208","author":"Stolfi","year":"2011","journal-title":"J Exp Med"},{"issue":"8","key":"2019111809442762300_B162","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"issue":"9","key":"2019111809442762300_B163","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.176.9.5213","article-title":"Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.","volume":"176","author":"Overwijk","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"2019111809442762300_B164","doi-asserted-by":"crossref","first-page":"e34959","DOI":"10.1371\/journal.pone.0034959","article-title":"A protective role by interleukin-17F in colon tumorigenesis.","volume":"7","author":"Tong","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"2019111809442762300_B165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-011-1318-9","article-title":"Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.","volume":"91","author":"Cho","year":"2012","journal-title":"Ann Hematol"},{"issue":"2","key":"2019111809442762300_B166","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma.","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111809442762300_B167","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T helper 17 cells promote cytotoxic T cell activation in tumor immunity.","volume":"31","author":"Martin-Orozco","year":"2009","journal-title":"Immunity"},{"issue":"55","key":"2019111809442762300_B168","doi-asserted-by":"crossref","first-page":"55ra78","DOI":"10.1126\/scitranslmed.3000448","article-title":"The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.","volume":"2","author":"Paulos","year":"2010","journal-title":"Sci Transl Med"},{"issue":"3","key":"2019111809442762300_B169","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2009-02-203935","article-title":"Type 17 CD8+ T cells display enhanced anti-tumor immunity [published online ahead of print May 26, 2009].","volume":"114","author":"Hinrichs","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111809442762300_B170","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature.","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B171","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late developmental plasticity in the T helper 17 lineage.","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B172","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/eji.200838475","article-title":"Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.","volume":"39","author":"Martin-Orozco","year":"2009","journal-title":"Eur J Immunol"},{"issue":"4","key":"2019111809442762300_B173","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri2958","article-title":"Genomic views of STAT function in CD4+ T helper cell differentiation.","volume":"11","author":"O\u2019Shea","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2019111809442762300_B174","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"2019111809442762300_B175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses.","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"issue":"8","key":"2019111809442762300_B176","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.30332","article-title":"Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.","volume":"63","author":"Cosmi","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2019111809442762300_B177","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/0008-5472.CAN-11-3432","article-title":"Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-\u03b3-secreting cells as they differentiate into effector T cells in vivo.","volume":"72","author":"Hama\u00ef","year":"2012","journal-title":"Cancer Res"},{"key":"2019111809442762300_B178","volume-title":"The Strategy of the Genes","author":"Waddington","year":"1957"},{"key":"2019111809442762300_B179","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","article-title":"CD4 memory T cells: What are they and what can they do?","volume":"21","author":"MacLeod","year":"2009","journal-title":"Seminars in Immunology"},{"issue":"10","key":"2019111809442762300_B180","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties.","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"issue":"7","key":"2019111809442762300_B181","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat Med"},{"issue":"19","key":"2019111809442762300_B182","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-10-0356","article-title":"Wnt\/beta-catenin signaling in T-cell immunity and cancer immunotherapy.","volume":"16","author":"Gattinoni","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019111809442762300_B183","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.4049\/jimmunol.1003497","article-title":"T cell factor-1 negatively regulates expression of IL-17 family of cytokines and protects mice from experimental autoimmune encephalomyelitis.","volume":"186","author":"Yu","year":"2011","journal-title":"J Immunol"},{"issue":"9","key":"2019111809442762300_B184","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni.1762","article-title":"T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma.","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111809442762300_B185","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J Clin Invest"},{"key":"2019111809442762300_B186","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","article-title":"CD8+ T-cell memory in tumor immunology and immunotherapy.","volume":"211","author":"Klebanoff","year":"2006","journal-title":"Immunol Rev"},{"issue":"11","key":"2019111809442762300_B187","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.4049\/jimmunol.0900519","article-title":"Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death.","volume":"183","author":"Shi","year":"2009","journal-title":"J Immunol"},{"key":"2019111809442762300_B188","author":"Coquet"},{"issue":"4","key":"2019111809442762300_B189","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2011.09.009","article-title":"Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells.","volume":"35","author":"Pepper","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"2019111809442762300_B190","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2011.08.016","article-title":"Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection.","volume":"35","author":"Marshall","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"2019111809442762300_B191","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2010.06.014","article-title":"Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation.","volume":"33","author":"Wirth","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"2019111809442762300_B192","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.stem.2012.01.011","article-title":"Stem-cell-like qualities of immune memory; CD4+ T cells join the party.","volume":"10","author":"Luckey","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"104","key":"2019111809442762300_B193","doi-asserted-by":"crossref","first-page":"ra100","DOI":"10.1126\/scitranslmed.3002949","article-title":"Human TH17 cells are long-lived effector memory cells.","volume":"3","author":"Kryczek","year":"2011","journal-title":"Sci Transl Med"},{"issue":"7","key":"2019111809442762300_B194","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20120994","article-title":"The origins, function, and regulation of T follicular helper cells.","volume":"209","author":"Ma","year":"2012","journal-title":"J Exp Med"},{"issue":"2","key":"2019111809442762300_B195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ni.1837","article-title":"Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.","volume":"11","author":"Crotty","year":"2010","journal-title":"Nat Immunol"},{"key":"2019111809442762300_B196","author":"Liu"},{"key":"2019111809442762300_B197","first-page":"621","article-title":"Follicular helper CD4 T cells (T-FH).","volume-title":"Annual Review of Immunology","author":"Crotty"},{"issue":"12","key":"2019111809442762300_B198","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111809442762300_B199","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/eji.201040848","article-title":"IL-22-producing CD4+ T cells: middle-men between the immune system and its environment.","volume":"40","author":"Trifari","year":"2010","journal-title":"Eur J Immunol"},{"key":"2019111809442762300_B200","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111809442762300_B201","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis.","volume":"130","author":"Kagami","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"11","key":"2019111809442762300_B202","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation.","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat Immunol"},{"issue":"7","key":"2019111809442762300_B203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ni.2303","article-title":"The many lives of IL-9: a question of survival?","volume":"13","author":"Wilhelm","year":"2012","journal-title":"Nat Immunol"},{"issue":"8","key":"2019111809442762300_B204","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nm.2868","article-title":"Nine lives for TH9s?","volume":"18","author":"Zou","year":"2012","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/13\/2402\/1364798\/2402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/13\/2402\/1364798\/2402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T14:58:13Z","timestamp":1687964293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/13\/2402\/31180\/Essentials-of-Th17-cell-commitment-and-plasticity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":204,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,3,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-09-378653","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}